Role of BIM Deletion Polymorphism and BIM Expression as Predictive Biomarkers to Maximize the Benefit of EGFR-TKI Treatment in EGFR-Positive NSCLC

OBJECTIVE: BIM is a modulator of apoptosis that is triggered by EGFR-TKIs. This study evaluated the role of BIM deletion and its expression as predictor of EGFR-TKI treatment outcome. METHODS: The medical record of 185 EGFR-positive advanced non-small cell lung cancer (NSCLC) patients with/ without...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Asian Pac J Cancer Prev
Main Authors: Incharoen, Pimpin, Charonpongsuntorn, Chanchai, Saowapa, Sakditad, Sirachainan, Ekaphop, Dejthevaporn, Thitiya, Kampreasart, Kaettipong, Trachu, Narumol, Muntham, Dittapol, Reungwetwattana, Thanyanan
Formato: Artigo
Idioma:Inglês
Publicado: West Asia Organization for Cancer Prevention 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7173394/
https://ncbi.nlm.nih.gov/pubmed/31870097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.12.3581
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares